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Abstract
Antisocial personality disorder, psychopathy, dissocial personality disorder and sociopathy are constructs that have
generally been used to predict recidivism and dangerousness, alongside being used to exclude patients from treat-
ment services. However, ‘antisocial personality disorder’ has recently begun to emerge as a treatment diagnosis, a
development reflected within cognitive behaviour therapy and mentalisation-based psychotherapy. Many of the
behaviour characteristics of antisocial personality disorder are, at the same time, being targeted by interventions at
criminal justice settings. A significantly higher proportion of published articles focusing on antisocial personality
concern treatment when compared to articles on psychopathy. Currently, the proposal for antisocial personality
disorder for the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, suggests a major change in the
criteria for this disorder. While the present definition focuses mainly on observable behaviours, the proposed revi-
sion stresses interpersonal and emotional aspects of the disorder drawing on the concept of psychopathy. The pre-
sent commentary suggests that developments leading to improvement in the diagnosis of this type of disorder
should, rather than focusing exclusively on elements such as dangerousness and risk assessment, point us to ways
in which patients can be treated for their problems.
Introduction
The personality disorder currently known as antisocial
personality disorder, as defined by the Diagnostic and
Statistical Manual of Mental Disorders, fourth edition
(DSM-IV), has a long history. It is a term often linked
to Prichard’s early 19th century concept of ‘moral insan-
ity’ [1]. The term antisocial personality has been appear-
ing in the DSM since its first edition in 1952, although
it was initially labelled antisocial reaction under socio-
pathic personality disturbance [2].
Several related concepts describe the personality pro-
blems that can lead to antisocial behaviour. These con-
cepts include psychopathy, dissocial personality disorder,
and antisocial personality disorder [3]. In general, more
than 50% of the variance of these constructs is shared
(see, for example, [3,4]), although the concept of psy-
chopathy encompasses a broader range of problems and
behaviours compared to the other two [5].
Antisocial personality disorder is a disorder that is
associated with substantial impairment of the indivi-
dual [6]. Moreover, antisocial personality disorder has
a negative impact on the people surrounding these
individuals, including, for example, children growing
up with a parent who has antisocial personality disor-
der [7], and spouses of people with antisocial personal-
ity disorder [8].
Given the impact that antisocial personality can have
on individuals and society in general, one should expect
that high priority be given to the development of effec-
tive treatments for this disorder. This is, however, not
the case. Indeed, many therapists appear to reject
patients with antisocial personality disorder [9]. More-
over, many antisocial personality disorder patients
report that they do not believe that their personality is
in need of change [10], and few treatments have actually
been developed for the disorder [11].
The next version of the DSM, the DSM-V is currently
in the pipeline. The key question now is, will the DSM-
V foster more research into ways in which people with
these types of problems can be helped or not?
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The proposed criteria for antisocial personality disor-
der are known as ‘antisocial/psychopathic prototype’.
Like the widely used Psychopathy Checklist-Revised
(PCL-R), this prototype encompasses antisocial beha-
viour, including aspects such as crime, interpersonal def-
icits, and callous-unemotional traits. What then would
happen if the new criteria were to be introduced? The
present commentary discusses the advantages and disad-
vantages of this development, in particular with a focus
on the likelihood that the new diagnostic criteria will
inspire the development of effective treatments.
Discussion
Overall, mental illness should primarily be diagnosed so
that patients can obtain optimal treatment. A secondary
aim should be to safeguard society against dangerous
individuals. For a disorder such as antisocial personality
disorder, both aims are highly relevant. If patients diag-
nosed as having an antisocial personality disorder do
not receive treatment, it may simply be because there is
no way to help such patients, or because such patients
are all ‘treatment rejecting’ [10].
Do we know for a fact that people with antisocial per-
sonality disorder cannot be treated? Experience with
other types of psychiatric illness suggests that there are
barriers to treatment, not all of which are intrinsic to
the disorder itself. For example, the stigma attached to
mental illness, the belief that available treatments will
not be helpful, and the basic level of public awareness of
the nature of mental illness, may all have an impact on
the behaviour of both the patients and their family
members, and also the behaviour of service providers
(see, for example, [12]).
Few treatments have been tested for antisocial or psy-
chopathic personality disorder. A review of psychosocial
treatments for antisocial personality disorder found 11
studies in total [11]. However, only two of these studies
can be considered to tailor specifically for antisocial per-
sonality disorder [13,14]. Nevertheless, findings reviewed
across a range of areas revealed that patients with anti-
social personality disorder are able to respond to treat-
ment options designed to target a number of the
symptoms associated with this condition [11]. These
symptoms include substance abuse, driving under the
influence, as well as anger and violence. Simultaneously
developers of mentalisation-based treatment for border-
line personality disorder are working to develop their
treatment to be appropriate for patients with comorbid
borderline and antisocial personality disorder [15].
Similarly, psychoeducational, group-based prison pro-
grammes have helped patients change their criminal
ways of thinking, reducing the risk of recidivism in turn
[16-18] and in general, correctional rehabilitation is
showing effects of practical significance for criminal
recidivism and offender functioning [19]. Therefore,
while it is true that the antisocial personality disorder
diagnosis can sometimes be used to refuse treatment to
patients, clinical research is becoming progressively
more interested in viewing this diagnosis as a target for
treatment.
What’s in a name?
As mentioned above, one change in the proposed cri-
teria is the introduction of the term ‘psychopathic’.
Another notable change is a higher focus on issues per-
taining to interpersonal and emotional aspects of the
psychopathology.
When it comes to the concept of psychopathy, the
main focus of this concept has been on its utility in for-
ensic settings, and very little has been concerned with
the effective treatment of patients.
The concept of psychopathy is strongly related to pre-
dicting the risk of recidivism in criminal behaviour; 7
years ago, a meta-analysis of the single most important
instrument used in psychopathy, the PCL-R, found 16
studies that had assessed the PCL-R as a predictor of
institutional adjustment, and 34 studies that had
assessed the PCL-R as a predictor of criminal recidivism
[20]. In contrast, research addressing psychopathy as a
target for treatment is far more limited.
Thus, while it has been claimed that psychological
treatments for psychopathy are ineffective or may even
worsen the outcome in patients, the evidence supporting
this claim is limited [21]. Where is the evidence that
suggests that psychopathic and antisocial patients can-
not be treated? The evidence rests mainly on findings
that indicate that psychopathy and, to a much lesser
extent, antisocial personality, represent a negative prog-
nostic factor in many contexts [5]. Conversely, although
it has been noted that higher severity predicts poorer
outcome, this does not mean that treatment cannot be
of some benefit; as mentioned above, many of the pro-
blems characteristic of individuals with psychopathy and
antisocial personality respond to such treatment. This
leads to the question: what would happen in this line of
research if the concept of psychopathy were to replace
the concept of antisocial personality disorder? Would
researchers and clinicians continue to refine tools for
evaluating dangerousness, and would the focus on treat-
ment and counselling slip out of focus?
A search on the PubMed database (conducted 15
August 2010) revealed that out of 1,678 hits on ‘psycho-
pathic personality’ or ‘psychopathy’, a total of 393 articles
contained words such as ‘psychotherapy’, ‘counselling’, or
‘treatment’ (23% of the articles). In comparison, 2,761 of
a total of 7,299 hits (38%) on ‘antisocial personality’ con-
tained the same words. While certainly not all of the
2,761 articles containing the word with ‘antisocial
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personality’ and mention of ‘psychotherapy’ or ‘counsel-
ling’ can be considered as representing important works
that drive a treatment agenda forward, it seems to imply
that the emerging interest in actually treating patients
with antisocial disorder is borne by the label of ‘antiso-
cial’, rather than the label of ‘psychopathy’.
Indeed, in an article concerning a recent trial of cogni-
tive behaviour therapy for antisocial personality disorder
and violence, the authors stated their surprise that the
patients with antisocial personality disorder were actu-
ally willing to enter treatment that was targeted for this
disorder [13]. My colleagues and I have noted the same
thing in an ongoing study taking place in substance
abuse treatment settings in Denmark (unpublished
results; Thylstrup and Hesse). Even in the absence of
tangible rewards, it appears that a number of antisocial
disorder patients are willing to try treatment and even
attend sessions when they are presented with a careful
description of their disorder and the problems that it
causes, and offered a treatment that targets this
disorder.
Like other socially disadvantaged patients, patients
with antisocial personality disorder have problems with
dropout rates and stability. However, psychiatric and
substance abuse treatment services should not give up
on the agenda of developing a range of treatments for
antisocial behaviours. Psychotherapy will not turn serial
killers or other extremely severe psychopaths into
responsible citizens, and psychotherapy does not cure
antisocial personality disorder. But many kinds of treat-
ment can potentially be helpful for groups of patients
whose behaviour is harming themselves and others.
The significance of subtypes for treatment
Research into subtypes of psychopathy generally sug-
gests that significant subtypes do exist. This research
suggests that subtypes exist within the group of patients
that have characteristics of psychopathy [22,23]. Some
patients with high levels of psychopathy have a very low
capacity for empathy, they experience low levels of anxi-
ety and depression, score highly on traits such as cal-
lousness and narcissism and they have a strong
tendency to use instrumental violence. Another group of
patients with high levels of psychopathy experience high
levels of symptoms such as anxiety and depression, as
well as high comorbidity of conditions such as border-
line personality disorder [24].
The latter group may be more responsive to treatment
and it appears that they have the ability to form a work-
ing alliance with a therapist or counsellor [15,25]. Once
again, this does not mean that we should exclude the
more severely affected patients from treatment, it sug-
gests that the development of effective treatments for
psychopathy may best be preceded by targeting the
patients who are comparatively easier to help, before
progressing onto the more severely affected patients.
What kind of treatment can be effective?
Wong and Hare have developed a set of guidelines list-
ing potentially helpful treatments for psychopathy [26].
These guidelines may also apply to antisocial behaviour
more generally. These guidelines include employing
moral reasoning as an active part of treatment, using a
cognitive behavioural approach, applying a social infor-
mation processing approach, and planning for relapse
prevention [26]. Additionally, one may add that treat-
ment needs to structured, and that patients should not
be required to address their emotional states. Asking the
patients about ‘feeling states’ is unlikely to be helpful to
those who have difficulty accessing such states, and who
may act out aggressively when confronted with a poten-
tial personal shortcoming. And finally, a high level of
external structure that may include supervision of the
patient [27], as well as contingent reinforcement of spe-
cific prosocial behaviours [28], is likely to lead to
improved outcomes in antisocial patients.
What could go wrong in clinical practice?
There is another issue aside from research resources.
The change in diagnostic criteria may also have an
impact on clinical practice. The shift to describing anti-
social behaviours within the broader concept of psycho-
pathy can lead clinicians to make mistakes in two ways:
the first is by failing to diagnose clinically relevant,
potentially treatable psychopathology, because a patient
with serious antisocial behaviour lacks additional fea-
tures of psychopathy, such as callousness or failure to
experience remorse. The second is by wrongly attribut-
ing these additional psychopathological features to
patients who do not have them, thus overdiagnosing the
disorder, but consequently failing to provide treatment,
based on the false belief that all patients with antisocial
personality are equally difficult to treat.
Therefore, the DSM-V should stress the interventions
that antisocial patients may respond to, as well as the
aspects of antisocial behaviours that may respond to
treatment. Also, given the considerable evidence sup-
porting the existence of clinically significant subtypes,
the text should mention these subtypes, and mention
that research indicating a very chronic and severe course
of the disorder may not apply equally to all subtypes.
While this is not standard in diagnoses, antisocial/psy-
chopathic personality disorder is not a standard psychia-
tric disorder.
Conclusions
Antisocial personality disorder is associated with suffer-
ing for the individual and, perhaps more so than any
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other psychiatric disorder, causes problems for people
living with antisocial patients. Antisocial behaviours
have been the target of several trials of psychosocial
treatments, and although there is still substantial room
for improvement, some of these treatments hold pro-
mise. The concept of psychopathy, however, has mainly
been studied in relation to the prediction of negative
outcomes. The DSM-V should provide clinicians with
the tools to distinguish between patients with serious
but potentially treatable behavioural problems among
psychiatric patients and patients with substance use dis-
orders, and patients whose pathology is more likely to
be chronic and less likely to respond to treatment.
The diagnostic criteria should reflect the fact that
some of the behavioural problems associated with anti-
social personality disorder respond to treatment, that
there is some evidence to support the effectiveness of
treatments, and that, therefore, the agenda should
remain on how to best help patients, not only produce
arguments as to why they should be kept in prison and
kept out of treatment.
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